Catalyst Wire Dossier Catalyst Wire Dossier

19(T2)28z1xx CAR T cells

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 19(T2)28z1xx CAR T cells, covering 2025-08-24 to 2025-08-24. Get the full timeline:

Most recent: Clinical Trial Update: 19(T2)28z1xx Chimeric Antigen Receptor (CAR) T Cells in People With B-Cell Cancers [Phase 1]

See pricing